Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

Gilead Sciences Inc. (GILD)

-NasdaqGS
104.27 Up 2.78(2.74%) Sep 2, 4:00PM EDT
|Pre-Market : 105.29 Up 1.02 (0.98%) 6:30AM EDT
Add to Portfolio
Prev Close:101.49
Open:103.44
Bid:104.90 x 100
Ask:105.28 x 200
1y Target Est:126.83
Beta:0.86019
Earnings Date:Oct 26 - Oct 30 (Est.)
Day's Range:101.02 - 104.30
52wk Range:85.95 - 123.37
Volume:11,512,348
Avg Vol (3m):10,808,300
Market Cap:153.03B
P/E (ttm):11.00
EPS (ttm):9.48
Div & Yield:0.43 (1.64%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 2.74%153.03B
PFEUp 1.95%197.17B
GSKUp 2.96%98.23B

Key Statistics

Forward P/E (1 yr):8.96
P/S (ttm):5.10
Ex-Dividend Date:14-Sep-15

Analysts

Annual EPS Est (Dec-15) :11.69
Quarterly EPS Est (Sep-15) :2.82
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback